Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.11 0.00 (-3.55%)
As of 09:30 AM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Key Stats

Today's Range
$0.11
$0.11
50-Day Range
$0.07
$0.10
52-Week Range
$0.07
$0.29
Volume
21,361 shs
Average Volume
408,904 shs
Market Capitalization
$41.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

Treasury Secretary Bessent Is Betting Big on Gold
When the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gold analyst believes Warren Buffett is preparing to follow suit… and he’s identified one gold miner big enough to absorb a portion of Buffett’s $330B cash pile. A key filing could confirm it by August 15th — and early investors may want to act now.
MariMed Announces Second Quarter 2025 Earnings Date
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.1158 at the beginning of 2025. Since then, MRMD shares have decreased by 5.1% and is now trading at $0.1099.

MariMed Inc. (OTCMKTS:MRMD) posted its quarterly earnings data on Wednesday, May, 7th. The company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The firm earned $37.96 million during the quarter, compared to analysts' expectations of $38.33 million. MariMed had a negative net margin of 10.33% and a negative trailing twelve-month return on equity of 10.21%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
5/07/2025
Today
7/22/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Previous Symbol
OTC:MRMD
CIK
1522767
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.16 million
Net Margins
-10.33%
Pretax Margin
-4.40%
Return on Equity
-10.21%
Return on Assets
-3.12%

Debt

Debt-to-Equity Ratio
1.21
Current Ratio
1.05
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$157.96 million
Price / Sales
0.27
Cash Flow
$0.03 per share
Price / Cash Flow
4.34
Book Value
$0.16 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
390,430,000
Free Float
316,291,000
Market Cap
$42.91 million
Optionable
Not Optionable
Beta
2.90
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners